FTSE 100

FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.

This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.

Compass Group plc 18.7% potential upside indicated by JP Morgan

Compass Group plc with ticker (LON:CPG) now has a potential upside of 18.7% according to JP Morgan.JP Morgan set a target price of 2,600 GBX for the company, which when..

INTERCONTINENTAL HOTELS GROUP Common Stock -10.8% potential downside indicated by Berenberg Bank

INTERCONTINENTAL HOTELS GROUP Common Stock with ticker (LON:IHG) now has a potential downside of -10.8% according to Berenberg Bank.Berenberg Bank set a target price of 7,400 GBX for the company,..

Rentokil Initial plc 15.5% potential upside indicated by RBC Capital Markets

Rentokil Initial plc with ticker (LON:RTO) now has a potential upside of 15.5% according to RBC Capital Markets.RBC Capital Markets set a target price of 575 GBX for the company,..

International Consolidated Airlns Grp SA 33.9% potential upside indicated by RBC Capital Markets

International Consolidated Airlns Grp SA with ticker (LON:IAG) now has a potential upside of 33.9% according to RBC Capital Markets.RBC Capital Markets set a target price of 200 GBX for..

GSK announces positive results from DREAMM-8 phase III trial for Blenrep

GSK plc announces positive results from DREAMM-8 trial evaluating Blenrep in combination with PomDex for multiple myeloma treatment. Exciting news for patients and potential treatment advancements...

Aviva plc 2023 results: Profit up 9%, Dividend Growth, and Confident Outlook

Discover Aviva plc's impressive 2023 Results Announcement, showcasing profitable growth and increased dividends. CEO Amanda Blanc highlights key achievements and future enhancements for shareholders and customers...

Beazley delivers record $1.25 billion profit in 2023

Beazley plc (LON:BEZ) announces strong financial results for 2023, including record profit and share buyback programme. CFO appointment and future growth plans outlined...

ConvaTec Group reports accelerating organic revenue growth of 7.2%

ConvaTec Group plc (LON:CTEC) reports strong annual results with 7.2% organic revenue growth, margin expansion and new product launches...

Legal & General reports record new business volumes and resilient in-year profit generation

Legal & General Group Plc unveils its full year 2023 results, highlighting strong performance and future growth opportunities. CEO António Simões shares insights and plans for sustained success...

Hiscox Ltd reports Record Profits and Growth in Full-Year Results 2023

Hiscox Ltd (LON:HSX) announced impressive full-year results for 2023, with record profit, strong growth, and a special return to shareholders...

Intertek reports highest LFL revenue growth in the last 10 years

Intertek Group plc (LON:ITRK) announces impressive full year results, with revenue growth, margin progression, and strong cash flow. CEO André Lacroix highlights key achievements and outlines positive outlook for 2024...

Ashtead Group strong operating performance continues with revenue up 14%

Ashtead Group plc (LON:AHT) delivers strong performance with revenue up 14% and rental revenue up 11% in nine months ending 31 January 2024. CEO Brendan Horgan comments on strategic growth..

GSK ViiV Healthcare reports Positive Findings for ultra long-acting HIV treatment Cabotegravir

GSK plc's ViiV Healthcare announces positive findings from a phase I study on cabotegravir ultra long-acting for HIV treatment. Exciting progress in long-acting medication development...

Intertek to acquire Base Met Labs, enhancing minerals testing capabilities

Intertek Group plc announces acquisition of Base Met Labs, a leading provider of metallurgical testing services in North America, enhancing Total Quality Assurance solutions in the Minerals sector...

AstraZeneca and Daiichi Sankyo’s Dato-DXd validated by EMA for lung and breast cancer treatment

AstraZeneca and Daiichi Sankyo's datopotamab deruxtecan (Dato-DXd) receives EMA validation for lung and breast cancer treatments, advancing the potential for improved patient outcomes...

Aviva plc acquires Probitas, entry into Lloyd’s market

Aviva plc (LON:AV) announces the acquisition of Probitas, expanding into the Lloyd's market for growth and profitability. Exciting developments ahead!..

Compass Group plc 19.0% potential upside indicated by JP Morgan

Compass Group plc with ticker (LON:CPG) now has a potential upside of 19.0% according to JP Morgan.JP Morgan set a target price of 2,600 GBX for the company, which when..

IMI plc 23.2% potential upside indicated by RBC Capital Markets

IMI plc with ticker (LON:IMI) now has a potential upside of 23.2% according to RBC Capital Markets.RBC Capital Markets set a target price of 2,150 GBX for the company, which..

Ashtead Group plc 19.1% potential upside indicated by JP Morgan

Ashtead Group plc with ticker (LON:AHT) now has a potential upside of 19.1% according to JP Morgan.JP Morgan set a target price of 6,800 GBX for the company, which when..

Relx PLC 18.5% potential upside indicated by JP Morgan

Relx PLC with ticker (LON:REL) now has a potential upside of 18.5% according to JP Morgan.JP Morgan set a target price of 4,100 GBX for the company, which when compared..

Search

Funds

FTSE 100

GSK announces positive results from DREAMM-8 phase III trial for Blenrep

GSK plc announces positive results from DREAMM-8 trial evaluating Blenrep in combination with PomDex for multiple myeloma treatment. Exciting news for patients and potential treatment advancements...

Aviva plc 2023 results: Profit up 9%, Dividend Growth, and Confident Outlook

Discover Aviva plc's impressive 2023 Results Announcement, showcasing profitable growth and increased dividends. CEO Amanda Blanc highlights key achievements and future enhancements for shareholders and customers...

Beazley delivers record $1.25 billion profit in 2023

Beazley plc (LON:BEZ) announces strong financial results for 2023, including record profit and share buyback programme. CFO appointment and future growth plans outlined...

ConvaTec Group reports accelerating organic revenue growth of 7.2%

ConvaTec Group plc (LON:CTEC) reports strong annual results with 7.2% organic revenue growth, margin expansion and new product launches...

Legal & General reports record new business volumes and resilient in-year profit generation

Legal & General Group Plc unveils its full year 2023 results, highlighting strong performance and future growth opportunities. CEO António Simões shares insights and plans for sustained success...

Hiscox Ltd reports Record Profits and Growth in Full-Year Results 2023

Hiscox Ltd (LON:HSX) announced impressive full-year results for 2023, with record profit, strong growth, and a special return to shareholders...

Intertek reports highest LFL revenue growth in the last 10 years

Intertek Group plc (LON:ITRK) announces impressive full year results, with revenue growth, margin progression, and strong cash flow. CEO André Lacroix highlights key achievements and outlines positive outlook for 2024...

Ashtead Group strong operating performance continues with revenue up 14%

Ashtead Group plc (LON:AHT) delivers strong performance with revenue up 14% and rental revenue up 11% in nine months ending 31 January 2024. CEO Brendan Horgan comments on strategic growth plans and market conditions...

GSK ViiV Healthcare reports Positive Findings for ultra long-acting HIV treatment Cabotegravir

GSK plc's ViiV Healthcare announces positive findings from a phase I study on cabotegravir ultra long-acting for HIV treatment. Exciting progress in long-acting medication development...

Intertek to acquire Base Met Labs, enhancing minerals testing capabilities

Intertek Group plc announces acquisition of Base Met Labs, a leading provider of metallurgical testing services in North America, enhancing Total Quality Assurance solutions in the Minerals sector...

AstraZeneca and Daiichi Sankyo’s Dato-DXd validated by EMA for lung and breast cancer treatment

AstraZeneca and Daiichi Sankyo's datopotamab deruxtecan (Dato-DXd) receives EMA validation for lung and breast cancer treatments, advancing the potential for improved patient outcomes...

Aviva plc acquires Probitas, entry into Lloyd’s market

Aviva plc (LON:AV) announces the acquisition of Probitas, expanding into the Lloyd's market for growth and profitability. Exciting developments ahead!..
Search

Funds

FTSE 100

FTSE 100

Funds